souseikai global clinical research center
 

Why Japan?

Five Reasons to think about Clinical Trials in Japan.

see details

 

Why SOUSEIKAI?

We will help your development's prosperity with multiple ways.

see details

Our Record

  • 34 years Phase 1 experience
  • 420 dedicated beds
  • 0 Major findings in 60 GCP inspections
  • 25,000+ Healthy Young Japanese Male/Female, 2,600+ Healthy Elderly Japanese Male/ Female, 550+ Healthy Young Caucasian Male/Female, 200+ Healthy Korean Male, 200+ Healthy Chinese Male, Patients

Our Studies

Top 3 Study Therapeutic Areas

Other Study Therapeutic Areas: Genitourinary, Dermatology, Vaccine, Gastroenterology, Endocrinology, Allergology, Chemotherapeutics, Antibiotic, PNS, Biosimilar, and more…

Our Clients

Out of the World Top 100 Pharmaceutical Companies by revenue in 2018 (Source: Novasecta), nearly half of the companies including 17 Japanese Major Pharma have chosen us as their study site!!